Vijaya Diagnostic Centre Limited reported a 20.4% year-on-year increase in revenue from operations to ₹1,880.5 million for the first quarter of FY26. The company's PAT stood at ₹383.4 million, with an EBITDA margin of 39.1%.
Vijaya Diagnostic Centre reported a revenue from operations of ₹1,880.5 million for Q1 FY26, marking a 20.4% increase compared to ₹1,562.2 million in Q1 FY25. The company's EBITDA stood at ₹735.3 million, with an EBITDA margin of 39.1%. Profit after Tax (PAT) was reported at ₹383.4 million, with a PAT margin of 20.4%.
The company performed 3.94 million tests in Q1 FY26, compared to 3.38 million tests in Q1 FY25. Footfalls increased to 1.10 million from 0.96 million in the same period last year. Revenue per test increased to ₹477 from ₹462, while revenue per footfall decreased to ₹1,707 from ₹1,621.
Ms. Suprita Reddy, MD & CEO of Vijaya Diagnostic Centre Ltd., commented on the Q1 FY26 results, noting the strong financial quarter with a 20.4% YoY growth. She highlighted the double-digit growth in the Hyderabad market and the operational status of new hubs in Pune, Bengaluru, and West Bengal. The Nizamabad hub centre achieved break-even within two quarters of full-fledged operations. The company plans to commission three hubs in Q2 FY26 across its Core Geography and West Bengal.
Vijaya Diagnostic Centre is strategically expanding in alignment with its vision. The company successfully acquired PH, Pune's largest B2C integrated diagnostic chain. Two hubs in HSR Layout and Yelahanka, Bengaluru, were inaugurated in Q1 FY26. The company is also on track to launch two more hubs in Nandyal and Khammam (AP & Telangana) by Q2 FY26.
All new hubs are now fully operational. The company is on track to commission a state-of-the-art hub in Nandyal (AP) and Khammam (Telangana) in Q2 FY26. Additionally, a hub in Kasba (WB) is also on track to be commissioned in Q2 FY26.
| Particulars | Q1 FY26 | Q1 FY25 | YoY Change | Q4 FY25 | QoQ Change | FY25 | FY24 | YoY Change |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 1,880.5 | 1,562.2 | 20.4% | 1,732.4 | 8.5% | 6,813.9 | 5,478.1 | 24.4% |
| Cost of materials consumed | 214.1 | 187.6 | 14.2% | 221.7 | -3.4% | 847.6 | 654.4 | 29.5% |
| Employee benefits expense | 316.1 | 273.6 | 15.5% | 284.0 | 11.3% | 1,121.5 | 902.2 | 24.3% |
| Other expenses | 615.0 | 488.6 | 25.9% | 538.1 | 14.3% | 2,112.6 | 1,712.5 | 23.4% |
| EBITDA | 735.3 | 612.4 | 20.1% | 688.6 | 6.8% | 2,732.2 | 2,209.0 | 23.7% |
| EBITDA Margin (%) | 39.1% | 39.2% | -10BPS | 39.8% | -65BPS | 40.1% | 40.3% | -23BPS |
| Other income | 70.5 | 35.6 | 97.8% | 55.5 | 27.0% | 183.2 | 208.2 | -12.0% |
| Depreciation and amortization expense | 208.9 | 166.3 | 25.6% | 188.2 | 11.0% | 706.0 | 570.0 | 23.9% |
| EBIT | 596.9 | 481.7 | 23.9% | 555.9 | 7.4% | 2,209.4 | 1,847.2 | 19.6% |
| Finance costs | 74.9 | 62.7 | 19.5% | 71.9 | 4.1% | 267.4 | 239.9 | 11.5% |
| Profit before Exceptional Items & Tax | 522.1 | 419.0 | 24.6% | 484.0 | 7.9% | 1,941.9 | 1,607.3 | 20.8% |
| Profit before Tax | 522.1 | 419.0 | 24.6% | 473.7 | 10.2% | 1,931.6 | 1,586.8 | 21.7% |
| Tax expenses | 136.2 | 104.0 | 31.0% | 125.1 | 8.9% | 493.7 | 390.4 | 26.4% |
| Profit before Minority Interest | 385.9 | 315.1 | 22.5% | 348.6 | 10.7% | 1,437.9 | 1,196.4 | 20.2% |
| Minority Interest | 2.5 | 1.6 | 56.4% | 2.3 | 10.1% | 7.2 | 8.1 | -11.5% |
| Profit after Tax (PAT) | 383.4 | 313.5 | 22.3% | 346.4 | 10.7% | 1,430.8 | 1,188.3 | 20.4% |
| PAT Margin (%) | 20.4% | 20.1% | 32BPS | 20.0% | 39BPS | 21.0% | 21.7% | -69BPS |
| EPS - Basic (INR) | 3.8 | 3.1 | 22.9% | 3.4 | 11.3% | 13.9 | 11.6 | 20.0% |
Financial Performance
Vijaya Diagnostic Centre reported a revenue from operations of ₹1,880.5 million for Q1 FY26, marking a 20.4% increase compared to ₹1,562.2 million in Q1 FY25. The company's EBITDA stood at ₹735.3 million, with an EBITDA margin of 39.1%. Profit after Tax (PAT) was reported at ₹383.4 million, with a PAT margin of 20.4%.
Operational Highlights
The company performed 3.94 million tests in Q1 FY26, compared to 3.38 million tests in Q1 FY25. Footfalls increased to 1.10 million from 0.96 million in the same period last year. Revenue per test increased to ₹477 from ₹462, while revenue per footfall decreased to ₹1,707 from ₹1,621.
Management Commentary
Ms. Suprita Reddy, MD & CEO of Vijaya Diagnostic Centre Ltd., commented on the Q1 FY26 results, noting the strong financial quarter with a 20.4% YoY growth. She highlighted the double-digit growth in the Hyderabad market and the operational status of new hubs in Pune, Bengaluru, and West Bengal. The Nizamabad hub centre achieved break-even within two quarters of full-fledged operations. The company plans to commission three hubs in Q2 FY26 across its Core Geography and West Bengal.
Strategic Expansion
Vijaya Diagnostic Centre is strategically expanding in alignment with its vision. The company successfully acquired PH, Pune's largest B2C integrated diagnostic chain. Two hubs in HSR Layout and Yelahanka, Bengaluru, were inaugurated in Q1 FY26. The company is also on track to launch two more hubs in Nandyal and Khammam (AP & Telangana) by Q2 FY26.
Key Developments
All new hubs are now fully operational. The company is on track to commission a state-of-the-art hub in Nandyal (AP) and Khammam (Telangana) in Q2 FY26. Additionally, a hub in Kasba (WB) is also on track to be commissioned in Q2 FY26.
